Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Gastroesophageal Reflux
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
- GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
- Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis
- Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
- The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease
- The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
- A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
- A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
- A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
- A Randomized, Double-Blind, Placebo-Controlled Study of PIMO to Treat Subjects With GERD
- Gastrointestinal Dysmotility on Aspiration Risk
- Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
- A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants
- Efficacy and Safety of Thread Embedding Acupuncture in Treating Gastroesophageal Reflux Disease
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
- The Effect of Physiotherapy on Post POEM Reflux
- Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease
- A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
- GCC Agonist Signal in the Small Intestine
- A Study to Compare PK, PD and Safety of the AD-214 and AD-2141
- A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
- A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
- Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal Impedance
- A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132
- The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole
- A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects
- Compassionate Use of Domperidone for Refractory Gastroparesis
- The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers
- A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
- A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole
- Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
- Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
- Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
- A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole
- Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures
- PPI Therapy Impact on GERD After Sleeve Gastrectomy
- Effects of Serotonin Agonist Citalopram on Multimodal Esophageal Stimulation in Healthy Volunteers
- Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers
- Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease
- Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
- Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease
- Physiology of GERD and Treatment Response
- Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
- Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
- GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy
- Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder
- Efficacy and Safety of HIP1601 Capsule
- Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
- Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.
- Efficacy of DA-5204 on Gastroesophageal Reflux Disease
- Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients
- Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
- Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
- A Placebo Controlled Trial With Baclofen for the Treatment of GERD Patients With Incomplete PPI Response
- The 90% Effective Sedation Dose Of Midazolam
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
- Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
- Effect of Citalopram on Reflux Episodes in Healthy Volunteers
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
- Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease
- A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks
- Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
- Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
- Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants
- Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease
- Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
- Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
- Fexofenadine Use in Gastroesophageal Reflux Symptoms
- Comparison of the Efficiency of Two Different PPI Formula in Atypical GERD
- Efficacy and Safety of DLBS2411 in the Management of GERD
- A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients
- Effectiveness of Physiologic Testing in PPI Non-Responders
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
- Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation
- Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis
- PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects
- Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects
- Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets
- Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
- Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
- Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease
- The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity
- Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)
- Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
- Methoclopramide for Gastroesophageal Reflux in Premature Infants
- Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)
- Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease
- Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
- Lesogaberan in Chinese Patients With Refractory Reflux Symptoms
- Implementation of PPI Medication PGX Testing
- Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection
- Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
- 48 Hours Esophagal pH-monitoring With and Without Gaviscon
- Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis
- A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
- Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)
- Pharmacodynamics and Safety of CDFR0209
- In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
- The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity
- Role of Pepsin Assay in Wheezy Infants
- Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease
- Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
- A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)
- Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study
- Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients
- A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
- GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals
- Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
- Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
- Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease
- The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
- The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease
- Dexlansoprazole MR in Nonerosive Reflux Disease
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
- PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects
- The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study
- Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
- Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
- The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate
- Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances
- S-pantoprazole 10mg Phase III Clinical Study
- Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
- Treatment Use of Domperidone for Gastroparesis
- Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- PK Study With Pantoprazole in Obese Children and Adolescents
- A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
- The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
- TAK-438 - Safety, Blood Levels & Effects of Repeated Doses
- Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity
- A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
- The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux
- Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets
- Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
- Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study
- Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy
- Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)
- Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors
- Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
- Response to Supplement and Placebo in GERD
- Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial
- Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD
- Gastroesophageal Reflux Treatment in Scleroderma
- Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients
- Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study
- Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate
- Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux
- Cromolyn Detection of Silent Aspiration
- Study of Erythromycin in GER-Associated Apnea of the Newborn
- A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus
- Lansoprazole in Preterm Infants With Reflux
- Anti-reflux Control to Decrease Post Tonsillectomy Pain
- Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn
- Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
- A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
- Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease
- A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease
- A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers
- Domperidone in Treating Patients With Gastrointestinal Disorders
- Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)
- Optimal Dosing of Omeprazole in Neonates
- The EndoGastric Solutions TEMPO Trial
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents
- Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain
- Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
- Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease
- Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
- Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC
- Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux
- The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors
- Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease
- To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
- Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD
- Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects
- Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis
- An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
- BRAVO Study for Functional Dyspepsia
- Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease
- Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
- Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
- Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
- The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux
- A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial
- A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
- Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects
- Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn
- Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
- Safety and Efficacy of Lansoprazole in Patients With Reflux Disease
- Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease
- Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
- Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
- Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.
- Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
- A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers
- Do Acid Sensing Ion Channels Contribute to Heartburn?
- Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD
- Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance
- Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients
- Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms
- Structure and Function of the Gastro-esophageal Junction
- Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease
- A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
- The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease
- Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)
- Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
- An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
- Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
- Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)
- A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
- Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
- The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
- Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
- Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
- Clinical Studies on Bile Acids in Barrett's Esophagus
- Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
- A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)
- Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy
- Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease
- Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
- Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
- A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease
- Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
- Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
- ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)
- Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH
- ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)
- A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
- Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP
- Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux
- Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
- AZD3355 Dose-escalation Study in Healthy Males
- A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive
- A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive
- Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants
- A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
- Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)
- Role of Mosapride in Patients With Gastroesophageal Reflux Disease
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
- Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
- Study to Compare Different Formulations of AZD3355
- Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
- Drug Interaction Study Between AZD3355 and Nexium
- Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.
- Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
- Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
- Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
- Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
- Quality of Life Validation in Laryngitis
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)
- Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
- Reflux Esophagitis Phase III Study (Maintenance Treatment)
- Reflux Esophagitis Phase III Study (Initial Treatment)
- An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflu
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn
- A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroe
- Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv
- Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
- Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD
- Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
- Lansoprazole to Treat Children With Asthma
- Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
- Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients
- SThe Effects of Melatonin on GERD Symptoms
- Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
- Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
- An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD
- Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.
- Domperidone for Gastroparesis in Solid Organ Transplantation
- Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.
- The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD
- Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
- Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children
- A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study
- Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
- The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population
- Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol
- Safety of Rabeprazole in Patients Under Multiple Treatments
- Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
- Esomeprazole and Gastric Emptying of Beer
- Phase 3/Safety & Efficacy of Esomeprazole in Infants
- A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
- The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)
- Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
- Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
- Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
- Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients
- Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
- Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
- A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
- Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
- Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
- PPI Sequencing Study
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)
- Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux
- Study Evaluating Pantoprazole in Adolescents With GERD
- Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)
- Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome
- Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD
- Elucidation of Acid-Induced Pulmonary Inflammation
- CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing
- Endoscopic Implantation of Enteryx for the Treatment of GERD
- Symptom Adapted Therapy in GERD Patients
- Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
- Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)
- Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)
- The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
- to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease
- Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)
- Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
- Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD
- Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
- Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
- Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
- Validation of RDQ Questionnaire
- Sleep Disorders and Gastroesophageal Reflux Disease (GERD)
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
- Prevacid vs Lifestyle Modifications for the Treatment of LPR
- Esomeprazole in PPI Failures - IMPROVE
- Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
- Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
- Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
- A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
- Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- ASTERIX: Low Dose ASA and Nexium
- Esomeprazole (NEXIUM) vs. Surgery
- Chest Pain Pilot Study
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn
- Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)
- Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
- HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease
- An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
- Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
- A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn
- A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
- A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)
- Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
- Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
- Esomeprazole for Treatment of GERD in Pediatric Patients
- Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
- Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
- Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
- A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.
- A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
- Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
- Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
- Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea
- NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
- Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
- Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis
- On Demand Treatment of Reflux Disease
- A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD
- A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease
- Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
- Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
- Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
- Maintenance Intermittent Therapy for Symptomatic GERD Patients
- A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease
- A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease
- Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy
- The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation
- Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
- A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)
- Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
- Study Evaluating Pantoprazole in Children With GERD
- Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
- Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants
- Study of Acid Reflux in Asthma
- Economic Impact of Guidelines for Gastroesophageal Reflux Disease
- Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux